News

Six-minute walk test results improved with stem cell therapy.

Stem Cell Studies Build Momentum toward Therapy for Age-Associated Frailty

Buoyed by promising results of a Phase I study demonstrating the safety of mesenchymal stem cell therapy to treat frailty in older adults, researchers at the Interdisciplinary Stem Cell Institute (ISCI) at the University of Miami Miller School of Medicine have taken it a step further. Now Phase II randomized, placebo-controlled trial findings have verified their initial study.

Read more on the Miller School website »

Joshua M. Hare, M.D.

Study Shows Stem Cell Therapy Dosing Matters in Ischemic Cardiomyopathy

The Phase II TRIDENT study, led by Joshua M. Hare, M.D., and colleagues at the University of Miami Miller School of Medicine, found that a dose of 100 million allogeneic human mesenchymal stem cells, versus 20 million, was more effective in decreasing scar tissue and restoring left ventricular ejection fraction in study of 30 people with ischemic cardiomyopathy.

Read more on the Miller School website »

The science of gene editing has been advancing more rapidly than have ethical guidelines for its use, say experts.

New Ethics Guidelines for Gene Editing

On August 3, The American Journal of Human Genetics published the American Society for Human Genetics’ policy statement on germline gene editing in humans. Representing the Miller School on the task force was Rosario Isasi, J.D., M.P.H., a bioethicist and lawyer whose work focuses on the regulation of human genetic technologies. We asked Isasi to discuss the policy statement and its broad implications.

Read more on the Miller School website »

Ranjith Ramasamy, M.D., speaking at American Urological Association conference in Boston.

Dr. Ranjith Ramasamy, Winner of AUA Research Scholar Award, Presents at Boston Conference

Ranjith Ramasamy, M.D., assistant professor of urology and director of male reproductive medicine and surgery at the University of Miami Miller School of Medicine, gave a presentation at the recent American Urological Association (AUA) annual meeting in Boston. Ramasamy specializes in the treatment of disorders of male infertility and sexual dysfunction.

Read more on the Miller School website »

51st Miami Winter Symposium Will Focus on Stem Cells

The 51st Miami Winter Symposium, to be held January 28-31, 2018, at the Hyatt Regency in Miami, will focus entirely on stem cells. Expert international speakers will give invited plenary talks supplemented by 12 selected ‘Spotlight’ talks and a large poster session.

Read more on the Miller School website »

News Archives »